Compare ADMA Biologics Inc (ADMA) vs United States Brent Oil Fund LP (BNO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ADMA Biologics Inc vs United States Brent Oil Fund LP — how do they compare? ADMA Biologics Inc trades at $9.86 (market cap $2.22B), while United States Brent Oil Fund LP trades at $50.53. The key difference: United States Brent Oil Fund LP is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | BNO | |
|---|---|---|
Market Cap | $2.22B | — |
Sector | Health | Commodities - Energy |
52-Week High | $20.38 | $60.13 |
52-Week Low | $7.60 | $27.20 |
Enterprise Value | $2.29B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About United States Brent Oil Fund LP
BNO is a commodity ETF that tracks the daily price of Brent crude oil futures. It provides exposure to the international oil benchmark, which often trades at a premium to the U.S. WTI benchmark, and is primarily used for short-term trading due to roll costs.
Read more on BNO →
